Bhatele Kirti Raj, Jha Anand, Kapoor Kavish, Tiwari Devanshu
RJIT, BSF Academy, Tekanpur, Gwalior, India.
Kavlabs, Gwalior, India.
Cogn Neurodyn. 2022 Dec;16(6):1361-1377. doi: 10.1007/s11571-022-09787-1. Epub 2022 Feb 9.
The two most generally diagnosed Neurodegenerative diseases are the Alzheimer and Parkinson diseases. So this paper presents a fully automated early screening system based on the Capsule network for the classification of these two Neurodegenerative diseases. In this study, we hypothesized that the Neurodegenerative diseases-Caps system based on the Capsule network architecture accurately performs the multiclass i.e. three class classification into either the Alzheimer class or Parkinson class or Healthy control and delivers better results in comparison other deep transfer learning models. The real motivation behind choosing the capsule network architecture is its more resilient nature towards the affine transformations as well as rotational & translational invariance, which commonly persists in the medical image datasets. Apart from this, the capsule networks overcomes the pooling layers related deficiencies from which conventional CNNs are mostly affected and unable to delivers accurate results especially in the tasks related to image classification. The various Computer aided systems based on machine learning for the classification of brain tumors and other types of cancers are already available. Whereas for the classification of Neurodegenerative diseases, the amount of research done is very limited and the number of persons suffering from this type of diseases are increasing especially in developing countries like India, China etc. So there is a need to develop an early screening system for the correct multiclass classification into Alzheimer's, Parkinson's and Normal or Healthy control cases. The Alzheimer disease and Parkinson progression (ADPP) dataset is used in this research study for the training of the proposed Neurodegenerative diseases-Caps system. This ADPP dataset is developed with the aid of both the Parkinson's Progression Markers Initiative (PPMI) and Alzheimer's disease Neuroimaging Initiative (ADNI) databases. There is no such early screening system exist yet, which can perform the accurate classification of these two Neurodegenerative diseases. For the sake of genuine comparison, other popular deep transfer learning models like VGG19, VGG16, ResNet50 and InceptionV3 are implemented and also trained over the same ADPP dataset. The proposed Neurodegenerative diseases-Caps system deliver accuracies of 97.81, 98, 96.81% for the Alzheimer, Parkinson and Healthy control or Normal cases with 70/30 (training/validation split) and performs way better as compare to the other popular Deep transfer learning models.
The online version contains supplementary material available at 10.1007/s11571-022-09787-1.
两种最常见的神经退行性疾病是阿尔茨海默病和帕金森病。因此,本文提出了一种基于胶囊网络的全自动早期筛查系统,用于这两种神经退行性疾病的分类。在本研究中,我们假设基于胶囊网络架构的神经退行性疾病 - Caps系统能够准确地进行多类别(即三类)分类,分为阿尔茨海默病类别、帕金森病类别或健康对照类别,并且与其他深度迁移学习模型相比能产生更好的结果。选择胶囊网络架构背后的真正动机是其对仿射变换以及旋转和平移不变性具有更强的适应性,这在医学图像数据集中普遍存在。除此之外,胶囊网络克服了传统卷积神经网络大多受影响的池化层相关缺陷,并且在与图像分类相关的任务中尤其无法给出准确结果。基于机器学习的各种用于脑肿瘤和其他类型癌症分类的计算机辅助系统已经存在。而对于神经退行性疾病的分类,所做的研究数量非常有限,并且患有这类疾病的人数正在增加,尤其是在印度、中国等发展中国家。因此,需要开发一种早期筛查系统,用于将其正确地多类别分类为阿尔茨海默病、帕金森病和正常或健康对照病例。本研究使用阿尔茨海默病和帕金森病进展(ADPP)数据集来训练所提出的神经退行性疾病 - Caps系统。这个ADPP数据集是在帕金森病进展标记物倡议(PPMI)和阿尔茨海默病神经影像学倡议(ADNI)数据库的帮助下开发的。目前还不存在这样一种能够对这两种神经退行性疾病进行准确分类的早期筛查系统。为了进行真正的比较,还实现了其他流行的深度迁移学习模型,如VGG19、VGG16、ResNet50和InceptionV3,并在相同的ADPP数据集上进行了训练。所提出的神经退行性疾病 - Caps系统在70/30(训练/验证分割)的情况下,对阿尔茨海默病、帕金森病和健康对照或正常病例的分类准确率分别为97.81%、98%、96.81%,并且与其他流行的深度迁移学习模型相比表现更好。
在线版本包含可在10.1007/s11571 - 022 - 09787 - 1获取的补充材料。